瘤学的健康公平原则真实世界证据研究研究
Patrice Forrester1, Henry Asante Antwi1, Nicholas J Robert2
1University of Maryland, School of Pharmacy, Baltimore, MD 21201, United States.
The oncologist
|July 17, 2024
概括
研究人员为社区癌症研究制定了原则,以促进健康公平. 这些指导方针涉及健康的社会决定因素 (SDOH),并促进在瘤学研究中包容性地使用患者记录数据.
科学领域:
- 在瘤学瘤学.
- 健康 公平 研究 健康 公平 研究
- 健康的社会决定因素
背景情况:
- 现实世界癌症研究必须整合健康的社会决定因素 (SDOH),以改善诊断,治疗和生存率的健康公平.
- 患者和利益相关者的意见对于开发研究原则至关重要,这些研究原则使用患者记录数据解决了健康公平问题.
研究的目的:
- 与患者和利益相关者共同开发研究原则,以指导在基于社区的瘤学研究中使用患者记录数据.
- 确保研究协议有效地解决健康平等和健康的社会决定因素.
主要方法:
- 采访了13名健康公平专家,SDOH和患者/社区咨询委员会成员.
- 利用快速的定性分析,从采访数据中识别主题和见解.
- 根据对瘤学研究中的健康公平和SDOH观点的分析,制定了研究原则.
主要成果:
- 确定了促进健康公平的三个关键类别:教育,社区参与和研究设计/实施.
- 教育原则强调必要的培训,以解决健康公平问题.
- 社区参与原则概述了包容性研究的行动,而设计/实施原则为规划,进行和传播研究提供了实际指导方针.
结论:
- 制定了指导瘤学实践研究协议的原则,以社区环境为指导,重点是SDOH和健康公平.
- 强调需要将这些原则定制为特定的癌症类型和社区,以获得最大的影响.
相关概念视频
Nursing Ethical Principles II
945
Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
945
Cancer Survival Analysis
336
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
336
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Ethical Issues
896
Nurses are essential in patient care, upholding the ethical principles of their profession and effectively navigating ethical dilemmas. Neglecting ethical issues can lead to inadequate patient care, compromised therapeutic relationships, and moral distress among healthcare workers.
Ethical Concerns in Healthcare:
Ethical Concerns in Healthcare:
896
Clinical Trials: Overview
2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K


